Seroba Kernel
Press Archives
2009 Press Releases
2008 Press Releases
2007 Press Releases
2006 Press Releases
2005 Press Releases
2004 Press Releases
2002 Press Releases

2007 Press
18th December
Merrion Pharmacueticals Plc admitted to the IEX
29th November
Alimentary Health’s Probiotic Technology Increased Availability In Stores – Marketed as Align® by Procter & Gamble
22nd November
Opsona Therapeutics Ltd In-Licenses Novel Anti-Inflammatory Modular from Nestle
20th November
Alimentary Health announces commencement of Clinical Study in Acute Diverticulitis
16th October
Recent Study Confirms Alimentary Health's Bifantis® Demonstrates Efficacy in the Treatment of Irritable Bowel Syndrome
18th September
Novate Medical Ltd secures €4m funding from ACT Venture Capital, Seroba Bioventures and Enterprise Ireland
12th September
FDA accepts IND filing for arverapamil (AGI-003) Phase III programme
15th August
Alimentary Health Announces Additional Clinical Studies Evaluation Agreement with Procter & Gamble
17th July
Alimentary Health Probiotic Now Available to U.S Pharmacits
8th June
Crescent Diagnostics Announces Positive Clinical Results for its Novel Bone Quality Test, BQT™
11th April
AGI Therapeutics plc FDA approval to file IND for Arverapamil Phase III study
11th April
AGI Therapeutics, plc Financial results for the twelve months ended 31 December 2006
15th February
Product update and outlook for 2007
1st February
Preliminary clinical data for mecamylamine (AGI-004) and arbaclofen (AGI-006)
25th January
Deerac Fluidics launches new high throughput liquid handling system
Alimentary Health’s Probiotic Technology Increased Availability In Stores – Marketed as Align® by Procter & Gamble


Cork Ireland, November 29, 2007 Alimentary Health Ltd. (Alimentary Health), a development stage specialty biotechnology company, welcomes the announcement by Procter & Gamble of the expanded distribution of its Align® product in three U.S. cities.

Align is the only probiotic supplement that contains Bifidobacterium infantis 35624, the Alimentary Health probiotic technology trademarked by P&G as Bifantis®.

Barry Kiely, CEO of Alimentary Health, commented: "Following on from Align’s wider availability through U.S. pharmacies in July 2007, the further expansion of Align’s distribution in the U.S. marks another significant step for Alimentary Health’s probiotic technology. We look forward to continuing this progress and welcome a gastroenterologist’s view and support of what we believe is a very exciting product."

For further information please contact:

Financial Dynamics

Tel: +44 (0) 20 7269 7193

Deborah Scott/John Dineen

Notes to Editors:

About Alimentary Health

Alimentary Health is a development stage specialty biotechnology company located in Ireland. The company is focused on the discovery, development and commercialization of proprietary probiotic and pharmabiotic treatments for gastrointestinal disorders and other inflammatory conditions. Alimentary Health is the foundation industry partner of the Alimentary Pharmabiotic Center based at University College Cork, Ireland.

Please visit www.alimentaryhealth.ie for more information


Announcement by Procter & Gamble

Procter & Gamble Brings Clinically Proven Probiotic to Store Shelves

CINCINNATI, Nov. 27 /PRNewswire/ -- Procter & Gamble (P&G) today announced that Align, a probiotic supplement new to store shelves, will now be sold in St. Louis, Cincinnati and Dallas. Align is a daily probiotic supplement – a source of healthy bacteria, that builds and maintains a natural defense against a full range of episodic digestive upsets, such as constipation, diarrhea, abdominal discomfort, urgency, gas and bloating*. Align is the only probiotic supplement that contains Bifantis® (Bifidobacterium infantis 35624), a natural probiotic strain clinically proven to help restore the balance of healthy bacteria in the digestive system.

"This is great news for my patients," says Dayna Early, M.D., gastroenterologist and Associate Professor of Medicine at Washington University in St. Louis. "In my practice I see a lot of people with episodic digestive issues and recent research suggests that Bifantis has the most solid data for helping this type of digestive upset. My patients will be happy to know that it is now available to them locally."

Bifantis has been rigorously tested and the data gathered from clinical trials validated its efficacy as a probiotic that can be helpful to the digestive system.

"We are very excited that Align will be more widely available to consumers with episodic digestive upsets," said Kristin Harper, Align Brand Manager. "At P&G, we are committed to advancing research and gaining a better understanding of digestive functioning. Probiotic supplements provide a different way of addressing digestive problems by supplying a consistent level of the specific bacterial strain that has been proven to build up healthy intestinal function over time."

Where to Find Align

In addition to being sold in select stores in St. Louis, Cincinnati and Dallas, Align is available nationally at any pharmacy counter. Align can also be ordered online at www.AlignGI.com or by phone at 1-800-208-0112.

About Align

Align is a lactose- and calorie-free daily probiotic supplement that helps build and maintain a strong and healthy digestive system.* Align works by providing a natural defense against episodic digestive upsets such as constipation, diarrhea, abdominal discomfort, urgency, gas and bloating. Align is the only probiotic supplement containing the probiotic ingredient Bifantis (Bifidobacterium infantis 35624).

Bifantis is the natural probiotic strain in Align. The specific and pure strain Bifantis is clinically proven to build and maintain a strong, healthy digestive system. Align is the only probiotic supplement that contains Bifantis. Experts believe the benefits of probiotics are strain-specific, and no other probiotic strain is backed by the strength of the clinical data supporting Bifantis. Please visit AlignGI.com for more information.

Align is sold in boxed blister packs of 28 easy-to-swallow capsules. The 28-day supply retails for approximately $32.99.


About Procter & Gamble

Three billion times a day, P&G brands touch the lives of people around the world. P&G has one of the strongest portfolios of quality, leadership brands in consumer health and wellness, including Actonel(R), Align(R), Always(R), Asacol(R), Crest(R), Enablex(R), Metamucil(R), Oral-B(R), Pepto-Bismol(R), Prilosec OTC(R), Scope(R), Tampax(R), and Vicks(R), in addition to its trusted consumer brands, including Ariel(R), Braun(R), Bounty(R), Charmin(R), Dawn(R), Downy(R), Duracell(R), Folgers(R), Gillette(R), Head & Shoulders(R), Iams(R), Lenor(R), Mach3(R), Olay(R), Pantene(R), Pampers(R), Pringles(R), Tide(R), Wella(R), and Whisper(R). The P&G community consists of over 135,000 employees working in over 80 countries worldwide. Please visit www.fd.com for the latest news and in-depth information about P&G and its brands.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Mo Noonan
Manager
Financial Communications

FD
Holborn Gate, 26 Southampton Buildings
London, WC2A 1PB

T +44 (0)20 7269 7116
F +44 (0)20 7242 8695
M +44 (0)7876 444 977

www.fd.com

London, New York, Bahrain, Beijing, Bogota, Boston, Cape Town, Chicago, Dubai, Dublin, Frankfurt, Hong Kong, Johannesburg, Los Angeles, Manchester, Moscow, Panama City, Paris, San Francisco, Shanghai, Sydney and Washington D.C.